Paragon Health Capital

Paragon Health Capital is a healthcare-focused financial advisory and broker-dealer firm formed in 2019 as a wholly owned subsidiary of Paragon Biosciences. The firm provides financing, capital raising, and M&A advisory services primarily to Paragon Biosciences' portfolio companies and other life science businesses. Its work spans growth financings from Series A through pre-IPO rounds, as well as strategic transaction support. Although it operates in the life sciences ecosystem, it is not a therapeutic product company and does not appear to run an internal drug pipeline. The business is best understood as a specialized healthcare capital markets and advisory platform supporting biotech and related healthcare companies.